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greater amplitude of far field potentials when performing catheter ablation in the left 
superior pulmonary vein. The results of this study also demonstrate that pulmonary vein 
anatomy is highly variable and that a different pattern of branching exists between the 
right and left pulmonary veins. 
11:30 a.m. 
859-5 Randomized Evaluation of the Utility of Intracardlac 
Echocardiogrsphy for AV Node Interventions 
~ ,  David Schwartzman, Atrial Arrhythmla Center, University of Pittsburgh, 
Pittsburgh, Pennsylvania. 
Background: The value of intracardiac echocardiography (ICE) for guiding transvenous 
catheter ablation procedures which target the AV node complex is unclear. Methods: The 
ICE catheter utilized incorporated a rotating transducer operating at 9 MHz (Boston Sci- 
entific). Patients undergoing complete AV node ablation (AVN, n=30) or slow pathway 
ablation (SP, n=10) were randomly assigned to ICE-guided or standard (eg. fluoroscopy/ 
electrogram-guided) technique. In the standard groups, ICE images were recorded but 
were unavailable to the operator for review until after the case. Results: (table shows 
median values; *p<.05 versus compadson group): All procedures were acutely success- 
ful. Total procedure duration, radiofrequency power, and ablation electrode maximum 
temperature were not significantly different. Based on the ICE images, in the standard 
groups the principal reason for individual esion failure was poor/unstable ablation elec- 
trode-endocardial contact. Intraprocedurally, in the AVN cohort 1 patient in the standard 
group required crossover to ICE. During followup (at least 6 months in each patient): in 
the AVN cohort 2 patients in the standard group experienced recurrence of AV nodal con- 
duction; in the SP cohort 1 patient in the ICE group expedencad spontaneous recurrence 
of AV nodal reentry. Conclusions: For catheter ablation or modification of the AV node, 
relative to standard technique the ICE-guided technique reduced fluoroscopy exposure 
and ablation lesion burden. 
AVN-iCE AVN-Standard SP-ICE SP-Standard 
Patients (n) 15 15 5 5 
Fluoro "rime (min) 0.0 * 3.1 0.2 * 5.5 
RF Lesions (n) 1 * 3 1 * 3 
11:45 a.m. 
859-6 Four Vessel Pu lmonary Vein Isolation Guided by Intra- 
Cardiac Echocardiography Without Contrast 
Venography In Patients With Drug Refractory 
Paroxysmal Atrial Fibrillation 
Viiendra Swaruo. Koji Azegemi, Mauricio S. Arruda, Martin C. Burke, Albert C. Lin, David 
J. Wilber, University of Chicago Hospitals, Chicago, Illinois. 
Background: Pulmonary vein (PV) isolation requires accurate definition of PV anatomy. 
Venography is time consuming and increases exposure to contrast and radiation. We 
present our experience with intracardlac echocardiography (ICE) to image and guide 
empiric isolation of all four PV without venography. Methods: 24 pts (age 49±10.6 yrs) 
with refractory paroxysmal atrial fibrillation (PAF) underwent circumferential mapping 
(Lasso, Biosense/Webster) and isolation of all four pulmonary veins with radiofrequency 
ablation. ICE (Acuson) was used to guide transseptal puncture, and determine PV diam- 
eters and flow velocities before and after ablation. During ablation, ICE was utilized to 
monitor catheter positioning. Results: All veins were successfully imaged by ICE and 
electrically isolated as documented by post ablation PV mapping. Mean duration of trans- 
septal catheterization was 134 ± 35 rain and fluoroscopy time was 41.8 -+ 13 min. There 
were only minor changes in PV diameters and flow velocities immediately post proce- 
dure. Spiral CT images at 3 months did not demonstrate PV stenosis or occlusion in any 
pt. No PAF was documented in 19/24 pts (79%) during short-term follow-up 
LtSuperior Lt Inferior Rt Superior Rt Infedor 
PV PV PV PV 
Diameter (cm) Pre 1.4 ± 0.2 1.6 + 0.2 1.7 ± 0.4 1.5 ±0.3 
Post 1.2 + 0.2 1.5 ± .2 1.6 ± 0.4 1.3 + 0.3 
PeekVeloclty(m/sec) Pro 0.56:t:0.15 0.53±0.13 0.56+0.18 0.46+0.09 
Post 0,75 ± 0.3 0.68 ± 0.26 0.59 + 0.15 0.56 + 0.12 
Conclusion: Exclusive use of ICE without venography to guide ablation of all four pulmo- 
nary veins is a feasible and practical strategy. Continuous reel-time guidance of energy 
delivery at the PV ostium may enhance both the safety and effectiveness of 4 vessel iso- 
lation relative to other imaging techniques. 
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1185-103 Associat ion of Angiotenein Convert ing Enzyme Gene 
Polymorphlam With Tachycardia Cardlomyopethy 
Pramod M. Deshmukh, John D. Noti, Mary A. Romanyshyn, Guthrie Clinic, Ltd, Say'e, 
Pennsylvania, Guthrie Research Institute, Sayre, Pennsylvania. 
Background: Insertion/deletion (I/D) polymorphism of angiotensin converting enzyme 
(ACE) gene has been implicated in ischemic and non-ischemic cardiomyopathy. How- 
ever, its relation to tachycardia cardiomyopathy is unknown. 
Methods: Twenty patients with persistent echycardla nd cardiomyopathy with ejection 
fraction (EF) 20 ± 7% showed improvement in EF to 43 ± 9% (p < 0.001) after interven- 
tions for rate control (Group A, tachycardla cardiomyopathy). A separate group of 
patients with a history of atrial arrhythmlas of 16 ± 15 months required interventions for 
rate control but maintained normal EF of 49 ± 5% (Group B, tachycardia without cardi- 
omyopathy). We compared I/D genotype frequency of Group A and B with that of healthy 
normal volunteers (Group C). 
Results: Gene frequency was significantly different in Groups A, B, and C (p < 0.002). 
Group A was significantly different from Group B (p < 0.035) and Group C (p < 0.009). 
Despite improvement, Group A's EF of 43% was significantly lower than Group B's EF of 
49% (p < 0.02). 
Conclusion: I/D poiymorphism of ACE gene may account for cardiomyopathy second- 
ary to tachycardla. 
1185-104 Assessment of Therapeutic Efficacy in 
Neurocardiogenic Syncope: Clomlprsmine Versus 
Isoproterenol Tilt Test 
Gaor?e N. Thendorakis, Dionyssios Leftheriotis, Efthimios G. Uvanis, Panagiota Flevari, 
Elias Zarvalis, Dimitrios T. Kramastinos, Onassis Cardiac Surgery Center, Athens, 
Greece. 
Background: In patients (pts) with recurrent neurocardiogenic syncope (NCS), evaluation 
of therapeutic efficacy by repeated heed-up tilt testing (HUT) with isoproterenot as drug 
challenge is questioned. Clomipramine has also been used dudng HUT for the diagnosis 
of NCS. In this study, we prospectively compared ciomipramine HUT with isoproterenol 
HUT in order to evaluate their relative efficacy in assessing response to treatment. Meth- 
ods: We studied 46 pts (17 men, 29 women, mean aged 36±17 years) with history of 
recurrent NCS and two consecutive positive HUTs (HUTs-I), one with clomipramine and 
the other with isoproperonoL The two tests were performed in a randomized sequence 
and an 24-hour interval was interspersed between them. Our pts were randomly treated 
with fiuoxetine or propranolol for 6 months and then the two HUTs were repeated in the 
same sequence (HUTs-2). We recorded the number of syncopal attacks during the last 6 
months before therapy and during the 6 months of treatment. We also examined whether 
the decrease in syncopal episodes during therapy was associated with the response to 
each of HUTs-2. Results: Fluoxetine and propranolol were equally effective in reducing 
syncopal attacks (4.0~1.8 before therapy vs 1.3±0.8 during therapy for fluoxetine and 
3.8±1.6 vs 1.1±1.5 respectively for propranolol, p:NS). Following therapy, a negative clo- 
mipramine HUT-2 was associated with a greater decrease in syncopal episodes (4.0±1.7 
vs 0.9¢1.2) than a positive clomipramine HUT-2 (3.9±1.3 vs 1.4±1.1), p<0.01. No such 
difference was observed between pts with a negative isoproterenol HUT-2 (3.9±1.2 vs 
1.2±1.1 ) and those with a positive isoproterenol HUT-2 (4.0±1.3 vs 1.0±1.0). Conclusion: 
In patients with NCS, clomipremine*HUT depicts therapeutic efficacy more accuretly than 
isoproterenoI-HUT. his may have important clinical implications. 
1185-105 Prevalence of Self-Reported Syncope: An 
Epidemiologic Study From Olmsted County, MN 
Lin Y. Chen, Win K. Shen, Douglas W. Mahoney, Steven J. Jacobsen, Richard J. 
Rodeheffer, Mayo Clinic, Rochester, Minnesota. 
Background: Although syncope is a common clinical syndrome with significant prognos- 
tic, psychosocial and economic implications, our current understanding of the prevalence 
of syncope is based on a few small studies in the past, and from very selected popula- 
tions. In this study, we estimated the prevalence of syncope in a cross-sectional survey 
of the adult population of OImsted County, MN. Methods: Residents of Olmstad County, 
MN >45 years of age were randomly sampled to take part in a cross-sectional study of 
left ventricular function in a population. A detailed questionnaire, which included ques- 
tions pertaining to syncope, was administered to the participants of the parent study. 
Subjects were specifically asked to respond to the following question, "Have you ever 
experienced a black-out?" The prevalence of syncope was estimated as the number of 
self-reported cases divided by the number responding to the questionnaire. The associa- 
tion of syncope prevalence with patient characteristics was investigated using a chi- 
square test of independence for categorical data and a chi-squara test of trend for ordinal 
data. Results: A total of 1925 subjects responded to the questions related to syncope. 
The median age of the participants was 61 years (Q1=53, Q3=71) and 905 (47.0%) were 
male. Overall, 364 subjects reported an episode of syncope in their lifetime giving a 
crude estimated prevalence of 19% (95% CI: 17% to 21%). There was no statistically sig- 
nificant association of syncope prevalence with age (p=0.86). Females reported a higher 
prevalence of syncope (22% vs. 15%, p<0.01 ). The median age of onset of syncope was 
25 years (Q1=15, Q2=50) with 47% having at least one recurrence. Females tended to 
report more recurrent episodes of syncope than males (51% vs. 41%), but this was not 
